World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Female Scientists 119 586 557 352 331 765 54447
Immunology 121 325 300 206 187 764 56407
Medicine 121 3597 3364 1985 1834 765 56415

Helen E. Heslop publications per year

The chart shows the history of publications by Helen E. Heslop between 1978 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Helen E. Heslop published across 48 years, from 1978 to 2025, averaging 17.6 papers a year. Output peaked at 64 publications in 2023. 34 of the 844 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1978 to 2025. Vertical axis: number of publications, 0 to 64. Peak 64 publications in 2023. 1978: 1 publication 1979: 1 publication 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 1 publication 1986: 1 publication 1987: 1 publication 1988: 3 publications 1989: 8 publications 1990: 8 publications 1991: 9 publications 1992: 2 publications 1993: 5 publications 1994: 12 publications 1995: 13 publications 1996: 11 publications 1997: 8 publications 1998: 11 publications 1999: 9 publications 2000: 11 publications 2001: 10 publications 2002: 19 publications 2003: 19 publications 2004: 27 publications 2005: 31 publications 2006: 29 publications 2007: 24 publications 2008: 36 publications 2009: 36 publications 2010: 34 publications 2011: 46 publications 2012: 24 publications 2013: 39 publications 2014: 38 publications 2015: 39 publications 2016: 38 publications 2017: 26 publications 2018: 20 publications 2019: 25 publications 2020: 18 publications 2021: 30 publications 2022: 23 publications 2023: 64 publications 2024: 23 publications 2025: 11 publications
1978 2025

844 publications in total across all disciplines

View publications per year as a table
Helen E. Heslop: publications per year, 1978 to 2025
Year Publications
1978 1
1979 1
1980 0
1981 0
1982 0
1983 0
1984 0
1985 1
1986 1
1987 1
1988 3
1989 8
1990 8
1991 9
1992 2
1993 5
1994 12
1995 13
1996 11
1997 8
1998 11
1999 9
2000 11
2001 10
2002 19
2003 19
2004 27
2005 31
2006 29
2007 24
2008 36
2009 36
2010 34
2011 46
2012 24
2013 39
2014 38
2015 39
2016 38
2017 26
2018 20
2019 25
2020 18
2021 30
2022 23
2023 64
2024 23
2025 11
Total 844
Download as CSV

Helen E. Heslop publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Helen E. Heslop sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 762–771 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 764 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7 764
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Helen E. Heslop D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Helen E. Heslop sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 120–121 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 121 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11 121
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Helen E. Heslop is affiliated with Baylor College of Medicine in the United States. Their research primarily focuses on medicine, with significant contributions to oncology, immunology, genetics, hematology, and molecular biology. The scientist's work includes investigations into CAR-T cell therapy research, virus-based gene therapy, immune cell function and interaction, hematopoietic stem cell transplantation, lymphoma diagnosis and treatment, viral infectious diseases and gene expression in insects, and acute lymphoblastic leukemia research.

Their recent papers include:

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma (2020, Journal of Clinical Oncology)
  • Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy (2021, Blood Cancer Discovery)
  • Unanswered questions following reports of secondary malignancies after CAR-T cell therapy (2024, Nature Medicine)
  • Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma (2020, Nature Communications)
  • Engineered off-the-shelf therapeutic T cells resist host immune rejection (2020, Nature Biotechnology)

Frequent co-authors include:

  • Malcolm K. Brenner
  • Premal Lulla
  • Carlos A. Ramos
  • Bambi Grilley
  • LaQuisa C. Hill

Helen E. Heslop has published extensively in the following venues:

  • Blood (24 publications)
  • Transplantation and Cellular Therapy (24 publications)
  • Journal of Clinical Oncology (12 publications)
  • Blood Advances (5 publications)
  • Molecular Therapy (4 publications)

The scientist's primary research topics can be summarized as:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • Lymphoma Diagnosis and Treatment
  • Viral Infectious Diseases and Gene Expression in Insects
  • Acute Lymphoblastic Leukemia research

Helen E. Heslop is a member of the Association of American Physicians.

Best Publications

  • Inducible apoptosis as a safety switch for adoptive cell therapy

    Antonio Di Stasi;Siok Keen Tey;Gianpietro Dotti;Yuriko Fujita

  • Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    Martin A. Pule;Barbara Savoldo;G. Doug Myers;G. Doug Myers;Claudia Rossig

  • Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

    C.M Rooney;C.Y.C Ng;S Loftin;C.A Smith

  • Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

    Chrystal U. Louis;Chrystal U. Louis;Barbara Savoldo;Barbara Savoldo;Gianpietro Dotti;Gianpietro Dotti;Martin Pule

  • Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

    Cliona M. Rooney;Colton A. Smith;Colton A. Smith;Catherine Y.C. Ng;Catherine Y.C. Ng;Susan K. Loftin;Susan K. Loftin

  • CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

    Barbara Savoldo;Carlos Almeida Ramos;Carlos Almeida Ramos;Enli Liu;Martha P. Mims

  • Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    Nabil Ahmed;Vita S. Brawley;Meenakshi Hegde;Catherine Robertson

  • Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

    Helen E. Heslop;Catherine Y.C. Ng;Congfen Li;Colton A. Smith

  • Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

    Helen E. Heslop;Karen S. Slobod;Martin A. Pule;Gregory A. Hale

  • An inducible caspase 9 safety switch for T-cell therapy

    Karin C. Straathof;Martin A. Pulè;Patricia Yotnda;Gianpietro Dotti

  • HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

    Nabil Ahmed;Nabil Ahmed;Vita Brawley;Vita Brawley;Meenakshi Hegde;Meenakshi Hegde;Kevin Bielamowicz

  • Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

    Yang Xu;Ming Zhang;Carlos A. Ramos;April Durett

  • Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

    Ann M. Leen;G. Doug Myers;Uluhan Sili;M. Helen Huls

  • Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

    Valentina Hoyos;Barbara Savoldo;Barbara Savoldo;Concetta Quintarelli;Aruna Mahendravada

  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall

  • A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

    Martin A. Pulè;Karin C. Straathof;Karin C. Straathof;Gianpietro Dotti;Gianpietro Dotti;Helen E. Heslop

  • T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

    Antonio Di Stasi;Biagio De Angelis;Cliona M. Rooney;Lan Zhang

  • Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

    Conrad Russell Y. Cruz;Kenneth P. Micklethwaite;Barbara Savoldo;Carlos A. Ramos

  • Post-transplant lymphoproliferative disorders.

    Stephen Gottschalk;Cliona M. Rooney;Helen E. Heslop

  • Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

    Catherine M. Bollard;Catherine M. Bollard;Stephen Gottschalk;Stephen Gottschalk;Vicky Torrano;Vicky Torrano;Oumar Diouf;Oumar Diouf

  • Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells

    Donna R. Rill;Donna R. Rill;Victor M. Santana;Victor M. Santana;W. Mark Roberts;W. Mark Roberts;Terri Nilson;Terri Nilson

Frequent Co-Authors

Malcolm K. Brenner
Malcolm K. Brenner Baylor College of Medicine
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine
Catherine M. Bollard
Catherine M. Bollard George Washington University
Adrian P. Gee
Adrian P. Gee Baylor College of Medicine
Ann M. Leen
Ann M. Leen Baylor College of Medicine
Gianpietro Dotti
Gianpietro Dotti University of North Carolina at Chapel Hill
Stephen Gottschalk
Stephen Gottschalk St. Jude Children's Research Hospital
Barbara Savoldo
Barbara Savoldo University of North Carolina at Chapel Hill
Hao Liu
Hao Liu Indiana University
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers within immunology and healthcare, pursuing specialized nursing degrees online is a practical option. Many students explore the cheapest psychiatric nurse practitioner programs to balance education quality with affordability, ensuring they can enter psychiatric care fields with minimal financial burden.

Understanding salary trends is essential when selecting a career path. Transparency in compensation is increasing, with detailed insights into dnp salary transparency helping professionals make informed decisions about where to work and specialize.

For nurses seeking to expand their scope of practice, transitioning between specialties is a common route. Resources on how to move from an FNP to acute care role provide guidance on certification requirements and skill development. Exploring a fnp to acute care certification can open new avenues in clinical care settings.

Accelerated pathways make advanced nursing degrees more accessible to qualified candidates. Programs highlighted in the nurse practitioner accelerated program category offer intensive, streamlined curriculums designed to quickly prepare students for practice as nurse practitioners.

Best Scientists Citing Helen E. Heslop

Trending Scientists

Recently Published Articles